Proposal No. 2: The proposal to approve, on an advisory basis, the compensation of the Company’s named executive officers, as set forth in the Fiscal 2025 Proxy Statement, was approved. There were 494,137,555 votes for, 49,908,008 votes against, and 3,039,793 abstentions. There were 151,130,744 broker non-votes on this proposal.
Proposal No. 3: The proposal to approve the Walgreens Boots Alliance, Inc. Amended and Restated 2021 Omnibus Incentive Plan was approved. There were 502,677,179 votes for, 41,235,538 votes against, and 3,172,639 abstentions. There were 151,130,744 broker non-votes on this proposal.
Proposal No. 4: The proposal to approve the Walgreens Boots Alliance, Inc. Employee Stock Purchase Plan, as amended and restated, was approved. There were 533,310,043 votes for, 11,674,621 votes against, and 2,100,692 abstentions. There were 151,130,744 broker non-votes on this proposal.
Proposal No. 5: The proposal to ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for fiscal year 2025 was approved. There were 660,848,906 votes for, 34,127,508 votes against, and 3,239,686 abstentions.
Proposal No. 6: The proposal to approve the amendment to the Company’s Amended and Restated Certificate of Incorporation to provide exculpation from liability for certain Company officers in certain circumstances as permitted by Delaware law was approved. There were 506,567,258 votes for, 37,384,850 votes against, and 3,133,248 abstentions. There were 151,130,744 broker non-votes on this proposal.
Proposal No. 7: The stockholder proposal requesting a report on cigarette waste was not approved. There were 37,541,144 votes for, 503,397,230 votes against, and 6,146,982 abstentions. There were 151,130,744 broker non-votes on this proposal.
Item 9.01. |
Financial Statements and Exhibits. |
(d) Exhibits